Search Results 21-30 of 15792 for Residual

1. A Study to Evaluate Outpatient Blinatumomab in Subjects with Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL) - Mayo Clinic

   A Study to Evaluate Outpatient Blinatumomab in Subjects with Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL) · Share · Facebook ...

2. Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL - Mayo Clinic

   The purpose of this study is to evaluate the rate of complete MRD response by flow cytometry after 4 weekly doses of daratumumab-hyaluronidase (Day 29) among ...

3. Sciatic Block in Contralateral Limb Phantom and Residual Limb Pain - Mayo Clinic

   The purpose of this study is to define the attributable pain relief and functional improvement in participants with PLP/RLP after contralateral limb sciatic ...

4. Neurosurgery - Clinical trials

   To access residual muscle specimens from diagnostic muscle biopsies obtained as part of the routine medical care. The biospecimens will be used to better ...

5. Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease - Mayo Clinic

   The purpose of this study is to determine what kind of chemotherapy to recommend to patients based on the presence or absence of circulating tumor DNA (ctDNA) ...

6. Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy - Mayo Clinic

   Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy ... residual disease. Ibrutinib may ...

7. Low Dose ColchicinE In PAtients With Peripheral Artery DiseasE To Address Residual Vascular Risk - Mayo Clinic

   The Low dose ColchicinE in pAtients with peripheral Artery DiseasE to address residual vascular Risk (LEADER-PAD) trial will evaluate if anti-inflammatory ...

8. Feasibility Study of MRI in Evaluation of Cardiovascular Parameters and Residual Breast Tissue in Transmasculine Patients - Mayo Clinic

   Feasibility Study of MRI in Evaluation of Cardiovascular Parameters and Residual Breast Tissue in Transmasculine Patients · Overview · Participation eligibility.

9. A Study of Sugammadex versus a Placebo for Prevention of Residual Neuromuscular Block - Mayo Clinic

   ... residual paralysis and an associated decrease in the incidence of postoperative respiratory depression. Participation eligibility. Participant eligibility ...

10. A Study to Evaluate Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients with Chronic Myeloid Leukemia and Persistently- Detectable Minimal Residual Disease - Mayo Clinic

    ... Residual Disease. Print details. Share; Facebook · Twitter. Overview; Participation ... residual disease, defined as the levels of a gene product called bcr ...